Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytes.

Abstract

BACKGROUND AND AIMS:

Cancer cells reprogram their metabolic pathways to support bioenergetic and biosynthetic needs and to maintain their redox balance. In several human tumors, the Keap1-Nrf2 system controls proliferation and metabolic reprogramming by regulating the pentose phosphate pathway (PPP). However, whether this metabolic reprogramming also occurs in normal proliferating cells is unclear.

APPROACH AND RESULTS:

To define the metabolic phenotype in normal proliferating hepatocytes, we induced cell proliferation in the liver by 3 distinct stimuli: liver regeneration by partial hepatectomy and hepatic hyperplasia induced by 2 direct mitogens: lead nitrate (LN) or triiodothyronine. Following LN treatment, well-established features of cancer metabolic reprogramming, including enhanced glycolysis, oxidative PPP, nucleic acid synthesis, NAD + /NADH synthesis, and altered amino acid content, as well as downregulated oxidative phosphorylation, occurred in normal proliferating hepatocytes displaying Nrf2 activation. Genetic deletion of Nrf2 blunted LN-induced PPP activation and suppressed hepatocyte proliferation. Moreover, Nrf2 activation and following metabolic reprogramming did not occur when hepatocyte proliferation was induced by partial hepatectomy or triiodothyronine.

CONCLUSIONS:

Many metabolic changes in cancer cells are shared by proliferating normal hepatocytes in response to a hostile environment. Nrf2 activation is essential for bridging metabolic changes with crucial components of cancer metabolic reprogramming, including the activation of oxidative PPP. Our study demonstrates that matured hepatocytes exposed to LN undergo cancer-like metabolic reprogramming and offers a rapid and useful in vivo model to study the molecular alterations underpinning the differences/similarities of metabolic changes in normal and neoplastic hepatocytes.

• Authors: Marta A Kowalik, Keiko Taguchi, Marina Serra, Andrea Caddeo, Elisabetta Puliga, Marina Bacci, Seizo Koshiba, Jin Inoue, Eiji Hishinuma, Andrea Morandi, Silvia Giordano, Andrea Perra, Masayuki Yamamoto, Amedeo Columbano
• Journal: Hepatology (Baltimore, Md.) (Hepatology) Vol. 79 Issue 4 Pg. 829-843 (Apr 01 2024) ISSN: 1527-3350 [Electronic] United States
• PMID: 37603610 (Publication Type: Journal Article)
• Copyright: Copyright © 2023 American Association for the Study of Liver Diseases.

Chemical References

• Kelch-Like ECH-Associated Protein 1
• NF-E2-Related Factor 2
• Triiodothyronine
• Nfe2l2 protein, rat

Topics

• Animals
• Humans
• Rats
• Cell Proliferation
• Hepatocytes (metabolism)
• Hyperplasia
• Kelch-Like ECH-Associated Protein 1 (metabolism)
• Metabolic Reprogramming
• Neoplasms (pathology)
• NF-E2-Related Factor 2 (metabolism)
• Triiodothyronine (genetics, metabolism)